• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Health-Related Quality of Life in Chronic Hepatitis C.慢性丙型肝炎患者的健康相关生活质量
GE Port J Gastroenterol. 2017 Mar;24(2):55-57. doi: 10.1159/000453319. Epub 2017 Jan 17.
2
Patient-reported outcomes of the Treatment and Prevention Study: A real-world community-based trial of direct-acting antivirals for hepatitis C among people who inject drugs.患者报告的治疗和预防研究结果：一项基于真实世界的、针对注射吸毒人群的丙型肝炎直接作用抗病毒药物的社区为基础的试验。
J Viral Hepat. 2021 Jul;28(7):1068-1077. doi: 10.1111/jvh.13516. Epub 2021 May 3.
3
Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B.与慢性乙型肝炎相比，慢性丁型肝炎患者报告的预后更差。
JHEP Rep. 2021 Mar 17;3(3):100280. doi: 10.1016/j.jhepr.2021.100280. eCollection 2021 Jun.
4
Only partial improvement in health-related quality of life after treatment of chronic hepatitis C virus infection with direct acting antivirals in a real-world setting-results from the German Hepatitis C-Registry (DHC-R).直接作用抗病毒药物治疗慢性丙型肝炎病毒感染的真实世界疗效：仅部分改善健康相关生活质量——德国丙型肝炎注册研究（DHC-R）的结果。
J Viral Hepat. 2021 Aug;28(8):1206-1218. doi: 10.1111/jvh.13546. Epub 2021 Jun 8.
5
Health-related quality of life and fatigue in patients with chronic hepatitis C with therapy with direct-acting antivirals agents interferon-free.慢性丙型肝炎患者直接作用抗病毒药物无干扰素治疗的健康相关生活质量和疲劳。
PLoS One. 2020 Aug 19;15(8):e0237005. doi: 10.1371/journal.pone.0237005. eCollection 2020.
6
Implementation of a pharmaceutical care program for patients with hepatitis C treated with new direct-action antivirals.为接受新型直接作用抗病毒药物治疗的丙型肝炎患者实施药学服务项目。
Int J Clin Pharm. 2019 Apr;41(2):488-495. doi: 10.1007/s11096-019-00809-3. Epub 2019 Apr 27.
7
Patient-reported outcomes with direct-acting antivirals for the treatment of chronic hepatitis C: current knowledge and outstanding issues.直接作用抗病毒药物治疗慢性丙型肝炎的患者报告结局：当前认知与突出问题
Expert Rev Gastroenterol Hepatol. 2017 Mar;11(3):259-268. doi: 10.1080/17474124.2017.1285227. Epub 2017 Jan 31.
8
SUSTAINED VIROLOGIC RESPONSE RATE IN CHRONIC HEPATITIS C PATIENTS THROUGH DIRECT-ACTING ANTIVIRALS THERAPY.通过直接抗病毒药物治疗慢性丙型肝炎患者的持续病毒学应答率
Arq Gastroenterol. 2019 Oct-Dec;56(4):394-398. doi: 10.1590/S0004-2803.201900000-79.
9
Editorial: direct-acting antivirals significantly improve quality of life in patients with hepatitis C virus infection.社论：直接抗病毒药物显著改善丙型肝炎病毒感染患者的生活质量。
Aliment Pharmacol Ther. 2018 Feb;47(4):536-537. doi: 10.1111/apt.14467.
10
Editorial: direct-acting antivirals significantly improve quality of life in patients with hepatitis C virus infection-Author's reply.社论：直接抗病毒药物显著改善丙型肝炎病毒感染患者的生活质量——作者回复
Aliment Pharmacol Ther. 2018 Feb;47(4):537-538. doi: 10.1111/apt.14481.

引用本文的文献

1
The Role of Direct-Acting Antivirals in Enhancing Quality of Life Among Individuals with Chronic Hepatitis C.直接抗病毒药物在提高慢性丙型肝炎患者生活质量中的作用。
Healthcare (Basel). 2025 Apr 11;13(8):878. doi: 10.3390/healthcare13080878.
2
Trends in Hospitalizations of Patients with Hepatitis C Virus in Poland between 2012 and 2022.2012年至2022年波兰丙型肝炎病毒患者住院情况趋势
J Clin Med. 2024 Sep 22;13(18):5618. doi: 10.3390/jcm13185618.
3
Assessment of hepatitis-related knowledge, attitudes, and practices on quality of life with the moderating role of internalized stigma among hepatitis B-positive patients in Pakistan.在巴基斯坦乙肝阳性患者中，以内化耻辱感为调节作用，评估肝炎相关知识、态度和行为对生活质量的影响。
Health Psychol Behav Med. 2023 Mar 30;11(1):2192782. doi: 10.1080/21642850.2023.2192782. eCollection 2023.
4
DEPRESSION, ANXIETY AND QUALITY OF LIFE IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION IN VOJVODINA.伏伊伏丁那慢性丙型肝炎病毒感染患者的抑郁、焦虑和生活质量。
Acta Clin Croat. 2021 Dec;60(4):579-589. doi: 10.20471/acc.2021.60.04.03.
5
Systematic Review of Health State Utility Values Used in European Pharmacoeconomic Evaluations for Chronic Hepatitis C: Impact on Cost-Effectiveness Results.系统评价在欧洲慢性丙型肝炎药物经济学评价中使用的健康状态效用值：对成本效益结果的影响。
Appl Health Econ Health Policy. 2021 Jan;19(1):29-44. doi: 10.1007/s40258-020-00600-w.

本文引用的文献

1
Corrigendum to 'EASL recommendations on treatment of hepatitis C: Final update of the series [J Hepatol 73 (2020) 1170-1218].《欧洲肝脏研究学会丙型肝炎治疗推荐：系列最终更新版》勘误 [《肝脏病学杂志》73卷（2020年）1170 - 1218页]
J Hepatol. 2023 Feb;78(2):452. doi: 10.1016/j.jhep.2022.10.006. Epub 2022 Dec 1.
2
Health-Related Quality of Life in Portuguese Patients with Chronic Hepatitis C.葡萄牙慢性丙型肝炎患者的健康相关生活质量
GE Port J Gastroenterol. 2017 Mar;24(2):68-78. doi: 10.1159/000450875. Epub 2016 Dec 3.
3
High incidence of hepatocellular carcinoma following successful interferon-free antiviral therapy for hepatitis C associated cirrhosis.丙型肝炎相关肝硬化无干扰素抗病毒治疗成功后肝细胞癌的高发病率
J Hepatol. 2016 Nov;65(5):1070-1071. doi: 10.1016/j.jhep.2016.07.027. Epub 2016 Jul 29.
4
Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials.在2型和3型慢性丙型肝炎患者中，索磷布韦和维帕他韦的不含利巴韦林方案具有高效性并能改善患者报告的结局：来自Astral-2和-3临床试验的结果
Clin Infect Dis. 2016 Oct 15;63(8):1042-1048. doi: 10.1093/cid/ciw496. Epub 2016 Jul 20.
5
Cognitive impairment in HIV and HCV co-infected patients: a systematic review and meta-analysis.HIV和HCV合并感染患者的认知障碍：一项系统评价和荟萃分析。
AIDS Care. 2015 Nov 5. doi: 10.1080/09540121.2015.1108385.
6
Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes.为了更全面地理解丙型肝炎持续病毒学应答与特定病因结局之间的关系。
Hepatology. 2015 Aug;62(2):355-64. doi: 10.1002/hep.27766. Epub 2015 Mar 25.
7
Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trials.用 ledipasvir 和 sofosbuvir 治疗可改善患者报告的结局：来自 ION-1、-2 和-3 临床试验的结果。
Hepatology. 2015 Jun;61(6):1798-808. doi: 10.1002/hep.27724. Epub 2015 Mar 18.
8
Patient-reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir-containing regimens.索磷布韦方案治疗肝硬化慢性丙型肝炎患者的患者报告结局。
Hepatology. 2014 Jun;59(6):2161-9. doi: 10.1002/hep.27161. Epub 2014 Apr 30.
9
Hepatitis C, stigma and cure.丙型肝炎、污名与治愈。
World J Gastroenterol. 2013 Oct 28;19(40):6703-9. doi: 10.3748/wjg.v19.i40.6703.
10
The burden of hepatitis C in Europe from the patients' perspective: a survey in 5 countries.欧洲丙型肝炎患者视角下的负担：5 国调查。
BMC Gastroenterol. 2013 Jan 17;13:16. doi: 10.1186/1471-230X-13-16.

Health-Related Quality of Life in Chronic Hepatitis C.

作者信息

Cardoso Helder, Silva Marco

机构信息

Gastroenterology Department, Hospitalar Center of São João, Faculty of Medicine of the University of Porto, Porto, Portugal.

出版信息

GE Port J Gastroenterol. 2017 Mar;24(2):55-57. doi: 10.1159/000453319. Epub 2017 Jan 17.

DOI:10.1159/000453319
PMID:28848783
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5553377/
Abstract
摘要